Ask what the plan will pay for.
Ask about the visit itself, then ask about any test or other care as its own item. A single answer about “the plan” can leave useful details open.
A visit and a product are different items.
As of September 2026, no TB-500 medicine is approved in the US, so no government drug-price programme publishes a price for an approved TB-500 medicine.
Those facts do not establish a coverage answer for your insurance plan. Ask for a written decision about the exact service or item you are considering.
Make the call easier
Bring the names and the quote.
Will the plan pay for this medical visit?
Give the clinician’s details and ask what you would owe.How are proposed tests handled?
Ask about each named test, where it would be done and any permission needed first.Does an ongoing fee qualify for payment?
Read the fee’s name from the written quote rather than describing the whole offer as a visit.Can I have the answer in writing?
Keep the explanation with the quote and visit notes.
Translate the terms
Ask what each word means for this bill.
A formulary names the medicines an insurance plan covers for payment.
With prior authorization, the plan must agree in advance to pay.
If those terms come up, ask which exact item they apply to. Ask what document would settle an open question.
If you have a medical spending account
Ask the person who runs the account too.
As of September 2026, IRS guidance distinguishes costs for treating a diagnosed disease from costs meant only to improve general health.
IRS is the short name for the Internal Revenue Service, the agency responsible for US taxes.
That general rule is not a decision that a TB-500 expense qualifies.
Ask the person or company that runs your medical spending account what records it needs. Ask whether the exact visit or item meets the account’s terms.